What are the differential diagnoses for arm weakness and hand discoloration in a 35‑week pregnant woman one day after receiving a tetanus, diphtheria, and acellular pertussis (Tdap) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnoses for Arm Weakness and Hand Discoloration After Tdap at 35 Weeks Gestation

The most likely diagnosis is a local injection site reaction with possible extensive limb swelling, though you must urgently rule out compartment syndrome, deep vein thrombosis, and neurologic complications such as brachial neuritis. 1, 2

Most Likely Vaccine-Related Diagnoses

Local Injection Site Reactions with Extensive Limb Swelling

  • Pain, swelling, and discoloration are common after Tdap, occurring in up to 79% of pregnant recipients for pain and 7.6% for swelling. 3
  • Extensive limb swelling can occur after tetanus toxoid-containing vaccines and typically resolves within 4-7 days without complication. 1
  • The "tired arms" likely represent significant injection site pain and myalgia, which are expected adverse effects. 3, 4
  • Hand discoloration may result from dependent edema and venous congestion secondary to proximal arm swelling. 1

Arthus Reaction (Type III Hypersensitivity)

  • This is a severe local vasculitis characterized by severe pain, swelling, induration, edema, hemorrhage, and occasionally local necrosis. 1
  • Onset is typically 4-12 hours after vaccination (not immediate like anaphylaxis). 1
  • More likely if the patient received a prior tetanus-containing vaccine within the past 2-5 years, as high preexisting antibody levels increase risk. 1
  • The discolored hands could represent hemorrhagic changes extending distally from the injection site. 1

Critical Neurologic Differentials to Rule Out

Brachial Neuritis (Parsonage-Turner Syndrome)

  • Tetanus toxoid-containing vaccines have a causal relationship with brachial neuritis, with a relative risk of 5-10 compared to background incidence. 2
  • Presents with severe shoulder and arm pain followed by weakness and atrophy of shoulder girdle muscles. 1, 2
  • Onset is typically days to weeks after vaccination. 2
  • The "tired arms" could represent early motor weakness rather than simple fatigue. 1

Guillain-Barré Syndrome (GBS)

  • While exceedingly rare (1 case when 2 expected by chance in 1.2 million doses), GBS has a possible causal relationship with tetanus toxoid-containing vaccines. 1, 2
  • Presents with ascending weakness, paresthesias, and autonomic dysfunction. 1
  • Onset is typically within 6 weeks of vaccination. 1, 2
  • Bilateral arm weakness would be concerning for early GBS. 1

Vascular/Thrombotic Differentials

Deep Vein Thrombosis (DVT)

  • Pregnancy is a hypercoagulable state, and DVT risk increases throughout gestation. 5
  • Arm swelling with discoloration could represent upper extremity DVT. 5
  • Large safety studies found no increased risk of venous thromboembolic events after Tdap in pregnancy, with slightly decreased rates in some cohorts. 5
  • However, this remains a critical diagnosis to exclude given the timing and symptoms. 5

Compartment Syndrome

  • Though rare, severe injection site swelling could theoretically progress to compartment syndrome. 1
  • Presents with severe pain, paresthesias, weakness, and pallor/discoloration. 1
  • This is a surgical emergency requiring immediate fasciotomy if confirmed. 1

Pregnancy-Related Differentials

Preeclampsia with Peripheral Edema

  • At 35 weeks, preeclampsia is a critical consideration for any new-onset swelling. 6
  • However, preeclampsia typically presents with bilateral lower extremity edema, not isolated upper extremity involvement. 6
  • One large study found a slightly increased adjusted relative risk of 1.38 for preeclampsia after Tdap, though this was consistent with background trends and did not exceed the safety threshold. 6

Carpal Tunnel Syndrome (Pregnancy-Related)

  • Common in late pregnancy due to fluid retention and median nerve compression. 5
  • Could cause hand paresthesias and perceived "tiredness" but would not explain discoloration. 5

Immediate Clinical Approach

History to Obtain

  • Exact timing of symptom onset relative to vaccination (immediate vs. hours vs. days). 1
  • Prior tetanus-containing vaccine history and timing (increased Arthus risk if <2-5 years). 1
  • Bilateral vs. unilateral symptoms (bilateral suggests systemic process like GBS). 1
  • Nature of "tired arms" (true weakness vs. pain-limited movement vs. fatigue). 1
  • Characteristics of discoloration (erythema vs. cyanosis vs. pallor vs. hemorrhagic). 1
  • Associated symptoms: fever, headache, visual changes, decreased fetal movement. 3, 6

Physical Examination Priorities

  • Measure bilateral arm circumferences to quantify swelling. 1
  • Assess injection site for severe erythema, induration, warmth, or necrosis (Arthus reaction). 1
  • Perform detailed neurologic examination including motor strength testing, reflexes, and sensory examination. 1
  • Evaluate for compartment syndrome: severe pain with passive stretch, tense compartments, paresthesias. 1
  • Check blood pressure and assess for preeclampsia signs (proteinuria, hyperreflexia, right upper quadrant pain). 6
  • Assess hand perfusion: capillary refill, pulses, temperature. 5

Diagnostic Testing

  • If true motor weakness is present, obtain urgent neurology consultation and consider nerve conduction studies/EMG for brachial neuritis or GBS. 1, 2
  • If DVT suspected, obtain upper extremity venous duplex ultrasound. 5
  • If compartment syndrome suspected, measure compartment pressures emergently. 1
  • Basic labs: CBC (thrombocytopenia), comprehensive metabolic panel, urinalysis (proteinuria for preeclampsia). 6

Management Based on Diagnosis

For Typical Local Reaction or Extensive Limb Swelling

  • Reassure that this is expected and will resolve within 4-7 days. 1, 3
  • Symptomatic management: ice, elevation, acetaminophen for pain. 3
  • Close follow-up to ensure resolution. 3

For Arthus Reaction

  • Symptomatic management as above. 1
  • Document that patient should not receive tetanus toxoid-containing vaccines more frequently than every 10 years, even for wound management. 1
  • Typically resolves without sequelae. 1

For Brachial Neuritis

  • Neurology consultation for confirmation. 2
  • Usually self-limited but may require physical therapy. 1
  • Not a contraindication to future tetanus-containing vaccines. 1

For GBS

  • Immediate hospitalization for monitoring of respiratory function and autonomic instability. 1
  • Neurology consultation for IVIG or plasmapheresis consideration. 1
  • History of GBS within 6 weeks of tetanus toxoid is a precaution for future doses. 1, 2

Critical Pitfalls to Avoid

  • Do not dismiss bilateral arm weakness as simple soreness without formal strength testing—this could be early GBS. 1
  • Do not assume all post-vaccine symptoms are benign—pregnancy complications like preeclampsia can coincidentally occur. 6
  • Do not forget to assess fetal well-being with non-stress test given maternal symptoms at 35 weeks. 6
  • Do not fail to document severe reactions in the medical record and report to VAERS. 7, 3
  • Remember that while Tdap is safe in pregnancy with no increased serious adverse events in large studies, individual severe reactions can still occur. 1, 3, 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adverse Effects of Tetanus Vaccine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Complications of Receiving Boostrix in Consecutive Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.